Advertisement
U.S. markets closed

Check-Cap Ltd. (CHEK)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.8221+0.0031 (+0.38%)
At close: 04:00PM EST

Check-Cap Ltd.

Check-Cap Building
29 Abba Hushi Avenue PO Box 1271
Isfiya 3009000
Israel
972 4 830 3401
https://www.check-cap.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Yoav Kimchy Ph.D.Founder, Head of R&D and Member of Scientific Advisory Board362.65kN/A1961
David BenaimInterim Chief Financial OfficerN/AN/AN/A
Ms. Noa Reshef M.B.A.Head of OperationsN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Corporate Governance

Check-Cap Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.